Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Moss

Showing results (241-250 of 308) with videos related to

Pageof 31
Sort By:
NPJ Vaccines|December 24, 2024
Mpox mRNA-1769 vaccine inhibits orthopoxvirus replication at intranasal, intrarectal, and cutaneous sites of inoculationCatherine A Cotter, Maxinne A Ignacio, Jeffrey L Americo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2003
Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine virusesIgor M Belyakov, Patricia Earl, Amiran Dzutsev, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Mpox mRNA-1769 Vaccine Inhibits Orthopoxvirus Replication at Intranasal, Intrarectal, and Cutaneous Sites of InoculationCatherine A Cotter, Maxinne A Ignacio, Jeffrey L Americo, et al.
Journal of Virology|June 13, 2014
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challengeSuefen Kwa, Lilin Lai, Sailaja Gangadhara, et al.
Virology|May 18, 2007
DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challengePragati Nigam, Patricia L Earl, Jeffrey L Americo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2008
Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virusPatricia L Earl, Jeffrey L Americo, Linda S Wyatt, et al.
Cancer Research|November 4, 2005
The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2Z Sheng Guo, Arpana Naik, Mark E O'Malley, et al.
Virology|August 9, 2005
Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R geneLydia Aldaz-Carroll, J Charles Whitbeck, Manuel Ponce de Leon, et al.
Human Gene Therapy|January 18, 2006
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primatesArpana M Naik, Sricharan Chalikonda, J Andrea McCart, et al.
Journal of Virology|October 4, 2015
Erratum for Gjessing et al., Salmon Gill Poxvirus, the Deepest Representative of the ChordopoxvirinaeMona C Gjessing, Natalya Yutin, Torstein Tengs, et al.
Pageof 31

Showing results (241-250 of 308) with videos related to

Sort By:
Pageof 31
NPJ Vaccines|December 24, 2024
Mpox mRNA-1769 vaccine inhibits orthopoxvirus replication at intranasal, intrarectal, and cutaneous sites of inoculationCatherine A Cotter, Maxinne A Ignacio, Jeffrey L Americo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2003
Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine virusesIgor M Belyakov, Patricia Earl, Amiran Dzutsev, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Mpox mRNA-1769 Vaccine Inhibits Orthopoxvirus Replication at Intranasal, Intrarectal, and Cutaneous Sites of InoculationCatherine A Cotter, Maxinne A Ignacio, Jeffrey L Americo, et al.
Journal of Virology|June 13, 2014
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challengeSuefen Kwa, Lilin Lai, Sailaja Gangadhara, et al.
Virology|May 18, 2007
DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challengePragati Nigam, Patricia L Earl, Jeffrey L Americo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2008
Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virusPatricia L Earl, Jeffrey L Americo, Linda S Wyatt, et al.
Cancer Research|November 4, 2005
The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2Z Sheng Guo, Arpana Naik, Mark E O'Malley, et al.
Virology|August 9, 2005
Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R geneLydia Aldaz-Carroll, J Charles Whitbeck, Manuel Ponce de Leon, et al.
Human Gene Therapy|January 18, 2006
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primatesArpana M Naik, Sricharan Chalikonda, J Andrea McCart, et al.
Journal of Virology|October 4, 2015
Erratum for Gjessing et al., Salmon Gill Poxvirus, the Deepest Representative of the ChordopoxvirinaeMona C Gjessing, Natalya Yutin, Torstein Tengs, et al.
Pageof 31